Treatment of suspected hyper-reactive malarial splenomegaly (HMS) in pregnancy with mefloquine

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 4, 2014, Pages 609-611

  Jaroensuk, Juthamas ^a   Stoesser, Nicole ^b   Leimanis, Mara L ^a   Jittamala, Podjanee ^a   White, Nicholas J ^a,c   Nosten, Francois H ^a,c,d   McGready, Rose ^a,c,d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SHOKLO MALARIA RESEARCH UNIT   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEFLOQUINE;

ADVERSE OUTCOME; ANEMIA; ANTIBODY TITER; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE TRANSMISSION; FEMALE; HUMAN; HYPER REACTIVE MALARIAL SPLENOMEGALY; IMMUNE RESPONSE; MALARIA; PREGNANCY; PREGNANT WOMAN; RECURRENT INFECTION; SPLEEN SIZE; SPLENOMEGALY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; FEMALE; HUMANS; HYPERSPLENISM; IMMUNOGLOBULIN M; MALARIA; MEFLOQUINE; PLASMODIUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RETROSPECTIVE STUDIES; SPLENOMEGALY;

EID: 84898757143     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0706     Document Type: Article

References (16)

1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, 2007. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93-104. (Pubitemid 46123132)
2. Rijken MJ, McGready R, Boel ME, Poespoprodjo R, Singh N, Syafruddin D, Rogerson S, Nosten F, 2013. Malaria in pregnancy in the Asia-Pacific region. Lancet Infect Dis 12: 75-88.
3. De Cock KM, Hodgen AN, Lucas SB, Jupp RA, Slavin B, Arap Siongok TK, Rees PH, 1987. Chronic splenomegaly in Nairobi, Kenya. I. Epidemiology, malarial antibody and immunoglobulin levels. Trans R Soc Trop Med Hyg 81: 100-106.
4. Singh RK, 2007. Hyper-reactive splenomegaly in expatriates. Travel Med Infect Dis 5: 24-29.
5. Bryceson A, Fakunle YM, Fleming AF, Crane G, Hutt MS, de Cock KM, Greenwood BM, Marsden P, Rees P, 1983. Malaria and splenomegaly. Trans R Soc Trop Med Hyg 77: 879.
6. A-Elgayoum SM, El-Rayah el-A, Giha HA, 2011. Validation of PCR for detection and characterization of parasitemia in massive splenomegaly attributed clinically to malaria infection. Diagn Microbiol Infect Dis 70: 207-212.
7. Puente S, Rubio JM, Subirats M, Lago M, Gonzalez-Lahoz J, Benito A, 2000. The use of PCR in the diagnosis of hyperreactive malarial splenomegaly (HMS). Ann Trop Med Parasitol 94: 559-563.
8. Bates I, Bedu-Addo G, 1997. Review of diagnostic criteria of hyper-reactive malarial splenomegaly. Lancet 349: 1178. (Pubitemid 27168568)
9. Crane G, 1989. The genetic basis of hyper-reactive malarious splenomegaly. P N G Med J 32: 269-276.
10. Sagoe AS, 1970. Tropical splenomegaly syndrome: long-term proguanil therapy correlated with spleen size, serum IgM, and lymphocyte transformation. BMJ 3: 378-382.
11. Van den Ende J, van Gompel A, van den Enden E, Taelman H, Vanham G, Vervoort T, 2000. Hyper-reactive malaria in expatriates returning from sub-Saharan Africa. Trop Med Int Health 5: 607-611.
12. Hamilton PJ, Gebbie DA, Hutt MS, Lothe F, Wilks NE, 1966. Anemia in pregnancy associated with "big spleen disease". BMJ 2: 548-551.
13. Bates I, 1991. Hyper-reactive malarial splenomegaly in pregnancy. Trop Doct 21: 101-103.
14. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356: 297-302. (Pubitemid 30459588)
15. Mothe B, Lopez-Contreras J, Torres OH, Muñoz C, Domingo P, Gurgui M, 2008. A case of hyper-reactive malarial splenomegaly. The role of rapid antigen-detecting and PCR-based tests. Infection 36: 167-169. (Pubitemid 351550326)
16. Paulson RR, Duvall KL, Codes JR, Holtan NR, 1984. Splenomegaly in Hmong refugees. Arch Intern Med 144: 257-260. (Pubitemid 14186813)